Medicare Benefits Schedule - Note TN.3.1

Search Results for Note TN.3.1

View Related Items

Category 3 - THERAPEUTIC PROCEDURES

TN.3.1

Therapeutic Dose of Yttrium 90 - (Item 16003)

This item cannot be claimed for selective internal radiation therapy (SIRT). 

See items 35404, 35406 and 35408 for SIRT using SIR_Spheres (yttrium-90 microspheres).

 

Related Items: 16003 35404 35406 35408


Related Items

Category 3 - THERAPEUTIC PROCEDURES

35404

35404 - Additional Information

Item Start Date:
01-May-2006
Description Updated:
01-May-2006
Schedule Fee Updated:
01-Nov-2023

DOSIMETRY, HANDLING AND INJECTION OF SIR-SPHERES for selective internal radiation therapy of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

The procedure must be performed by a specialist or consultant physician recognised in the specialties of nuclear medicine or radiation oncology on an admitted patient in a hospital. To be claimed once in the patient's lifetime only.

Fee: $381.50 Benefit: 75% = $286.15

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)

Category 3 - THERAPEUTIC PROCEDURES

35406

35406 - Additional Information

Item Start Date:
01-May-2006
Description Updated:
01-May-2006
Schedule Fee Updated:
01-Nov-2023

Trans-femoral catheterisation of the hepatic artery to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

excluding associated radiological services or preparation, and excluding aftercare

(Anaes.) (Assist.)

Fee: $895.20 Benefit: 75% = $671.40

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)

Category 3 - THERAPEUTIC PROCEDURES

35408

35408 - Additional Information

Item Start Date:
01-May-2006
Description Updated:
01-May-2006
Schedule Fee Updated:
01-Nov-2023

Catheterisation of the hepatic artery via a permanently implanted hepatic artery port to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

excluding associated radiological services or preparation, and excluding aftercare

(Anaes.) (Assist.)

Fee: $671.50 Benefit: 75% = $503.65

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)

Category 3 - THERAPEUTIC PROCEDURES

16003

16003 - Additional Information

Item Start Date:
01-Dec-1991
Description Updated:
01-Jul-2023
Schedule Fee Updated:
01-Nov-2023

Intra-cavitary administration of a therapeutic dose of Yttrium 90 (not including preliminary paracentesis and other than a service to which item 35404, 35406 or 35408 applies or a service associated with selective internal radiation therapy)

(Anaes.)

Fee: $1,562.00 Benefit: 75% = $1,171.50 85% = $1,463.30

(See para TN.3.1 of explanatory notes to this Category)


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change